Nanoscale surface modification favors benign biofilm formation and impedes adherence by pathogens

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 3, 2012, Pages 261-270

  Trautner, Barbara W ^a,b   Lopez, Analette I ^c   Kumar, Amit ^c   Siddiq, Danish M ^b   Liao, Kershena S ^b   Li, Yan ^c   Tweardy, David J ^b   Cai, Chengzhi ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c University of Houston   (United States)

Author keywords

Adherence; Biofilm; Enterococcus faecalis; Escherichia coli; Monolayer

Indexed keywords

ADHERENCE; ADVERSE EVENTS; AMIDATION; AMINO-TERMINATED; BIOFILM FORMATION; CATHETER SURFACE; E. COLI; ENTEROCOCCUS FAECALIS; FUTURE APPLICATIONS; HUMAN STUDY; IN-VITRO; INTERFERENCE EFFECTS; MANNOSE DERIVATIVES; NANO-SCALE SURFACES; RISK REDUCTIONS; SILICON SUBSTRATES; SILICON SURFACES; SURFACE COLONIZATION; URINARY CATHETERS; URINARY TRACT INFECTIONS;

BACILLI; BIOFILMS; CARBOXYLIC ACIDS; CATHETERS; FLUORESCENCE MICROSCOPY; LIGANDS; MONOLAYERS;

ESCHERICHIA COLI;

CARBOXYLIC ACID; MANNOSE; NANOMATERIAL; SILICONE;

AMIDATION; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; BIOFILM; CHEMICAL MODIFICATION; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ENZYME IMMOBILIZATION; ESCHERICHIA COLI; FIMBRIA; FLUORESCENCE MICROSCOPY; NONHUMAN; SURFACE PROPERTY;

BACTERIAL ADHESION; BIOFILMS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FIMBRIAE, BACTERIAL; HUMANS; MANNOSE; NANOSTRUCTURES; PHOTOELECTRON SPECTROSCOPY; SURFACE PROPERTIES;

ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI;

EID: 84862776802     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.11.014     Document Type: Article

References (30)

1. Haley R.W., Culver D.H., White J.W., Morgan W.M., Emori T.G. The nationwide nosocomial infection rate. A new need for vital statistics. Am J Epidemiol 1985, 121:159-167.
2. Warren J.W., Tenney J.H., Hoopes J.M., Muncie H.L., Anthony W.C. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis 1982, 146:719-723.
3. Gribble M., Puterman M. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole. Am J Med 1993, 95:141-152.
4. Warren J., Anthony W., Hoopes J., Muncie H. Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients. JAMA 1982, 248:454-458.
5. Archive, Agency for Healthcare Research and Quality Prevention and management of urinary tract infections in paralyzed persons. Summary. Evidence report/technology assessment: Number 6. AHRQ (updated January 1999) Available from. http://archive.ahrq.gov/clinic/epcsums/utisumm.htm.
6. Ha U.S., Cho Y.H. Catheter-associated urinary tract infections: new aspects of novel urinary catheters. Int J Antimicrob Agents 2006, 28:485-490.
7. Costerton J., Lewandowski S., Caldwell D., Korber D., Lappin-Scott H. Microbial biofilms. Annu Rev Microbiol 1995, 49:711-745.
8. Svanborg C., Bergsten G., Fischer H., Godaly G., Gustafsson M., Karpman D., et al. Uropathogenic Escherichia coli as a model of host-parasite interaction. Curr Opin Microbiol 2006, 9:33-39.
9. Danese P. Antibiofilm approaches: prevention of catheter colonization. Chem Biol 2002, 9:873-880.
10. Darouiche R., Smith J., Hanna H., Dhabuwala C., Steiner M., Babaian R., et al. Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. Urology 1999, 54:976-981.
11. Jahn P., Preuss M., Kernig A., Seifert-Huhmer A., Langer G. Types of indwelling urinary catheters for long-term bladder drainage in adults. Cochrane Database Syst Rev 2007, CD004997.
12. Sofer M., Denstedt J.D. Encrustation of biomaterials in the urinary tract. Curr Opin Urol 2000, 10:563-569.
13. Prasad A., Cevallos M.E., Riosa S., Darouiche R.O., Trautner B.W. A bacterial interference strategy for prevention of UTI in persons practicing intermittent catheterization. Spinal Cord 2009, 47:565-569.
14. Sunden F., Hakansson L., Ljunggren E., Wullt B. Bacterial interference-is deliberate colonization with Escherichia coli 83972 an alternative treatment for patients with recurrent urinary tract infection?. Int J Antimicrob Agents 2006, 28:S26-S29.
15. Trautner B.W., Hull R.A., Thornby J.I., Darouiche R.O. Coating urinary catheters with an avirulent strain of Escherichia coli as a means to establish asymptomatic colonization. Infect Control Hosp Epidemiol 2007, 28:92-94.
16. Andersson P., Engberg I., Lidin-Janson G., Lincoln K., Hull R., Hull S., et al. Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect Immun 1991, 59:2915-2921.
17. Trautner B.W., Cevallos M.E., Li H., Riosa S., Hull R.A., Hull S.I., et al. Increased expression of type-1 fimbriae by nonpathogenic Escherichia coli 83972 results in an increased capacity for catheter adherence and bacterial interference. J Infect Dis 2008, 198:899-906.
18. Bouckaert J., Berglund J., Schembri M., De Genst E., Cools L., Wuhrer M., et al. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Mol Microbiol 2005, 55:441-455.
19. Yam C.M., Lopez-Romero J.M., Gu J.H., Cai C.Z. Protein-resistant monolayers prepared by hydrosilylation of alpha-oligo(ethylene glycol)-omega-alkenes on hydrogen-terminated silicon (111) surfaces. Chem Commun 2004, 2510-2511.
20. Perring M., Dutta S., Arafat S., Mitchell M., Kenis P.J.A., Bowden N.B. Simple methods for the direct assembly, functionalization, and patterning of acid-terminated monolayers on Si(111). Langmuir 2005, 21:10537-10544.
21. Arafat S.N., Dutta S., Perring M., Mitchell M., Kenis P.J.A., Bowden N.B. Mild methods to assemble and pattern organic monolayers on hydrogen-terminated Si(111). Chem Commun 2005, 3198-3200.
22. Hull R.A., Gill R.E., Hsu P., Minshew B.H., Falkow S. Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate. Infect Immun 1981, 33:933-938.
23. Orndorff P.E., Falkow S. Organization and expression of genes responsible for type 1 piliation in Escherichia coli. J Bacteriol 1984, 159:736-744.
24. Chang A., Cohen S. Construction and characterization of multicopy amplifiable DNA cloning vehicles derived from the P15A cryptic miniplasmid. J Bacteriol 1978, 134:1141-1156.
25. Nieto C., Espinosa M. Construction of the mobilizable plasmid pMV158GFP, a derivative of pMV158 that carries the gene encoding the green fluorescent protein. Plasmid 2003, 49:281-285.
26. Trautner B., Darouiche R., Hull R., Hull S., Thornby J. Pre-inoculation of urinary catheters with Escherichia coli 83972 inhibits catheter colonization by Enterococcus faecalis. J Urol 2002, 167:375-379.
27. Trautner B., Hull R., Darouiche R. Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens. Urology 2003, 61:1059-1062.
28. Wang H., Chen S.F., Li L.Y., Jiang S.Y. Improved method for the preparation of carboxylic acid and amine terminated self-assembled monolayers of alkanethiolates. Langmuir 2005, 21:2633-2636.
29. Sam S., Touahir L., Andresa J.S., Allongue P., Chazalviel J.N., Gouget-Laemmel A.C., et al. Semiquantitative study of the EDC/NHS activation of acid terminal groups at modified porous silicon surfaces. Langmuir 2010, 26:809-814.
30. Cicero R., Linford M., Chidsey C. Photoreactivity of unsaturated compounds with hydrogen-terminated silicon (111). Langmuir 2000, 16:5688-5695.